Literature DB >> 20228830

Open channel block of Kv1.5 currents by citalopram.

Hyang Mi Lee1, Sang June Hahn, Bok Hee Choi.   

Abstract

AIM: To examine whether selective serotonin reuptake inhibitor citalopram interacts with Kv1.5, one of the cardiovascular-specific Kv channel isoforms.
METHODS: The interaction between citalopram and Kv1.5 expressed in Chinese hamster ovary cells was studied using the whole-cell patch-clamp technique.
RESULTS: Citalopram reduced Kv1.5 whole-cell currents in a reversible concentration-dependent manner, with an IC(50) value and a Hill coefficient of 2.8+/-1.1 micromol/L and 0.8+/-0.3, respectively. Citalopram-induced inhibition of Kv1.5 is associated with time-dependent development of block without modifying the kinetics of current activation. The inhibition increased steeply between -30 and 0 mV, which corresponded with the voltage range for channel opening. In the voltage range positive to 0 mV, inhibition displayed an additional voltage dependence, consistent with an electrical distance delta of 0.19. Citalopram slowed the deactivation time course, resulting in a tail crossover phenomenon when the tail currents, recorded in the presence and absence of citalopram, were superimposed. Inhibition of Kv1.5 by citalopram was use-dependent.
CONCLUSION: The present results suggest that citalopram acts on Kv1.5 currents as an open-channel blocker, and much caution about arrhythmogenic risk is required when using citalopram in the treatment with depressed patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228830      PMCID: PMC4007671          DOI: 10.1038/aps.2010.14

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  37 in total

1.  Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents.

Authors:  Harry J Witchel; Vijay K Pabbathi; Giovanna Hofmann; Ashok A Paul; Jules C Hancox
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

2.  Citalopram toxicity.

Authors:  M Personne; H Persson; E Sjöberg
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

3.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.

Authors:  J G Reilly; S A Ayis; I N Ferrier; S J Jones; S H Thomas
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

Review 5.  Epidemiology and relative toxicity of antidepressant drugs in overdose.

Authors:  J A Henry
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

6.  Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.

Authors:  L Bjerkenstedt; L Flyckt; K F Overø; O Lingjaerde
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Kinetics of citalopram in man; plasma levels in patients.

Authors:  K Fredricson Overø
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

Review 8.  [Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants].

Authors:  Pál Pacher; Valéria Kecskeméti
Journal:  Orv Hetil       Date:  2004-02-22       Impact factor: 0.540

9.  Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain.

Authors:  R Swanson; J Marshall; J S Smith; J B Williams; M B Boyle; K Folander; C J Luneau; J Antanavage; C Oliva; S A Buhrow
Journal:  Neuron       Date:  1990-06       Impact factor: 17.173

10.  Real-World Data on SSRI Antidepressant Side Effects.

Authors:  Elisa Cascade; Amir H Kalali; Sidney H Kennedy
Journal:  Psychiatry (Edgmont)       Date:  2009-02
View more
  9 in total

1.  Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.

Authors:  Imju Jeong; Shin Hee Yoon; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-27       Impact factor: 3.000

Review 2.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

3.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

4.  Inhibition of Kv4.3 potassium channels by trazodone.

Authors:  Yun Ju Chae; Jin-Sung Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-25       Impact factor: 3.000

5.  Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule.

Authors:  Vivek Garg; Frank B Sachse; Michael C Sanguinetti
Journal:  J Gen Physiol       Date:  2012-09       Impact factor: 4.086

6.  Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel.

Authors:  Hyang Mi Lee; Ok Hee Chai; Sang June Hahn; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

7.  Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells.

Authors:  Han Sol Kim; Hongliang Li; Hye Won Kim; Sung Eun Shin; Mi Seon Seo; Jin Ryeol An; Kwon-Soo Ha; Eun-Taek Han; Seok-Ho Hong; Il-Whan Choi; Grace Choi; Dae-Sung Lee; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2017-06-26       Impact factor: 2.016

8.  Blockade of Kv1.5 channels by the antidepressant drug sertraline.

Authors:  Hyang Mi Lee; Sang June Hahn; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

9.  Blockade of Kv1.5 by paroxetine, an antidepressant drug.

Authors:  Hyang Mi Lee; Sang June Hahn; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2015-12-31       Impact factor: 2.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.